$ASMB News Article - Assembly Biosciences Doses Fi
Post# of 39
(Total Views: 159)
Posted On: 11/14/2022 1:10:52 PM
$ASMB News Article - Assembly Biosciences Doses First Subject in Phase 1a Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of Investigational Next Generation Core Inhibitor ABI-4334 https://marketwirenews.com/news-releases/asse...44982.html
(0)
(0)Assembly Biosciences Inc. (ASMB) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼